Recently, a retrospective study on RCC tumor microarray using immunohistochemistry was performed to consider the prognostic value of TG2 along with proteins important in the regulation of transcription, cell cycle, growth signaling and apoptosis, as well as DNA damage and chromatin dynamics. The gene discussed is TGM2; the disease is renal cell carcinoma.